Alembic Pharmaceuticals Q4 Results
- BSE: 533573
- NSE: APLLTD
- ISIN: INE901L01018
- Sector: Biotechnology & Drugs
BSE
830.65
-6.75 (-0.81%)
-6.75 (-0.81%)Volume11.06 K
Updated: Mon 13 Jul, 2026 | 15:43:11
NSE
831.05-6.35 (-0.76%)
-6.35 (-0.76%)Volume1.01 L
Updated: Mon 13 Jul, 2026 | 15:43:11
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹1,847.72 Cr.(4.41%)
- Operating Profit₹114.58 Cr.(-43.54%)
- Profit After Tax₹202.70 Cr.(29.22%)
- Operating Margin6.20%(-45.92%)
Note: Comparison is on YoY basis
Quarterly - Alembic Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,733.14 | 1,705.16 | 1.64% | 1,326.40 | 10.62% |
| Depreciation/ Amortization | 88.59 | 80.12 | 10.57% | 69.48 | 28.41% |
| Operating Income | 114.58 | 171.15 | -33.05% | 190.58 | -43.54% |
| Net Income | 202.70 | 132.98 | 52.43% | 178.21 | 29.22% |
| Other Operating Expenses Total | 648.74 | 621.13 | 4.45% | 475.72 | 13.12% |
| Net Income Before Taxes | 118.63 | 161.50 | -26.54% | 182.85 | -38.19% |
| Total Revenue | 1,847.72 | 1,876.31 | -1.52% | 1,516.98 | 4.41% |
| Selling/ General/ Admin Expenses Total | 438.91 | 432.71 | 1.43% | 401.84 | 11.51% |
| Diluted Normalized EPS | 11.13 | 8.51 | 30.67% | 9.07 | 38.24% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.